FR2834891B1 - Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate - Google Patents

Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate

Info

Publication number
FR2834891B1
FR2834891B1 FR0200793A FR0200793A FR2834891B1 FR 2834891 B1 FR2834891 B1 FR 2834891B1 FR 0200793 A FR0200793 A FR 0200793A FR 0200793 A FR0200793 A FR 0200793A FR 2834891 B1 FR2834891 B1 FR 2834891B1
Authority
FR
France
Prior art keywords
ethyl
amino
ethyl4
fluoren
benzoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200793A
Other languages
English (en)
Other versions
FR2834891A1 (fr
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to FR0200793A priority Critical patent/FR2834891B1/fr
Priority to PCT/FR2003/000199 priority patent/WO2003061647A1/fr
Priority to ARP030100196A priority patent/AR038306A1/es
Publication of FR2834891A1 publication Critical patent/FR2834891A1/fr
Application granted granted Critical
Publication of FR2834891B1 publication Critical patent/FR2834891B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0200793A 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate Expired - Fee Related FR2834891B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0200793A FR2834891B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate
PCT/FR2003/000199 WO2003061647A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3- (trifluoromethyl) phenyl]ethyl}amino) ethyl-4-(2-{[2-(9h- fluoren-9-yl)acetyl] amino}ethyl)benzoate
ARP030100196A AR038306A1 (es) 2002-01-23 2003-01-23 Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200793A FR2834891B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate

Publications (2)

Publication Number Publication Date
FR2834891A1 FR2834891A1 (fr) 2003-07-25
FR2834891B1 true FR2834891B1 (fr) 2004-02-27

Family

ID=27589557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200793A Expired - Fee Related FR2834891B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate

Country Status (3)

Country Link
AR (1) AR038306A1 (fr)
FR (1) FR2834891B1 (fr)
WO (1) WO2003061647A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2966828B1 (fr) * 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
FR2677647B1 (fr) * 1991-06-14 1993-08-20 Adir Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.

Also Published As

Publication number Publication date
AR038306A1 (es) 2005-01-12
WO2003061647A1 (fr) 2003-07-31
FR2834891A1 (fr) 2003-07-25

Similar Documents

Publication Publication Date Title
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
FR2894475B1 (fr) Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
IS7714A (is) Lyfjasamsetningar úr módafíníl
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
MA27116A1 (fr) Preparation pharmaceutique contenant de l'oxycodon e et du naloxone
DE60232701D1 (de) Polymerverbindung enthaltend Siliciumestergruppen und diese enthaltende Zusammensetzungen
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
BR0307060A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
FR2857263B1 (fr) Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
FR2834893B1 (fr) Composition pharmaceutique orodispersible de perindopril
ITMI20021684A1 (it) Composizione farmaceutica di peptide nasale
FR2843020B1 (fr) Composition cosmetique comprenant un melange d'esters de dextrine
FR2834891B1 (fr) Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
FR2857593B1 (fr) Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2847818B1 (fr) Composition pharmaceutique a base d'acide hyaluronique
DE60102925D1 (de) Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen
FR2839888B1 (fr) Complexes d'inclusion de fenofibrate et de cyclodextrine et composition pharmaceutique les renfermant
FR2834892B1 (fr) Composition pharmaceutique orodispersible de mitiglinide
AU2003215707A1 (en) Orodispersible pharmaceutical composition comprising 2-({2-methoxy-2- (3-(trifluoromethyl) phenyl)ethyl}amino) ethyl-4-(2-{ (2-(9h- fluoren-9-yl) acetyl)amino} ethyl)benzoate
DK1652836T3 (da) Aminosyrediamider i non-alfa-stilling, som egner sig som adjuvanser til administration af aktrive biologiske midler

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081029